Gene Editing Has Arrived
A new gene therapy has just been approved as a treatment for the inherited blood disease, sickle cell disease, in the UK and...
Professor Merlin Crossley is Deputy Vice-Chancellor Academic Quality and a professor of molecular biology at UNSW. His lab works on CRISPR gene editing to treat inherited blood diseases.
Professor Crossley's research on sickle cell disease and gene editing were funded by grants from the Australian Research Council (ARC) and the National Health and Medical Research Council (NHMRC). Professor Crossley also receives funding via an Australian Research Council Linkage Grant with CSL Behring.
A new gene therapy has just been approved as a treatment for the inherited blood disease, sickle cell disease, in the UK and...
Impakter informs you through the ESG news site and empowers your business CSRD compliance and ESG compliance with its Klimado SaaS ESG assessment tool marketplace that can be found on: www.klimado.com
Registered Office Address
Klimado GmbH
Niddastrasse 63,
60329, Frankfurt am Main, Germany
IMPAKTER is a Klimado GmbH website
Impakter is a publication that is identified by the following International Standard Serial Number (ISSN) is the following 2515-9569 (Printed) and 2515-9577 (online – Website).
Office Hours - Monday to Friday
9.30am - 5.00pm CEST
stories [at] impakter.com
© 2025 IMPAKTER. All rights reserved.